GLENMARK Pharmaceuticals has launched Zonofade, its pioneering diabetes skincare range formulated to meet the unique needs of people living with diabetes.
The new range, which includes three purpose-driven products - Daily Skin Conditioner, Wound Support Gel and Skin Barrier Support Cream - features PTT-6, a patented stem cell complex that has been scientifically formulated to support the skin barrier function and resilience of diabetic skin.
With key ingredients including growth factors, collagen, hyaluronic acid, curcumin and urea, the products deliver targeted hydration, nourishment and protection to skin that is often fragile, dry or slow to heal due to the impact of diabetes.
"This is more than skincare - for vulnerable diabetic patients it's about restoring confidence, comfort and control in the daily maintenance of their skin," said Michael Moffitt, country manager, Australia & New Zealand at Glenmark Pharmaceuticals.
To order, call Pharmabrokers on (02) 8878 9733.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jan 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jan 26
